Explore Fulcrum Therapeutics, Inc.'s 8-K filing detailing significant events, stock info, and essential company data for shareholders as of February 25, 2025.
Discover Omega Therapeutics’ latest 8-K filing, including financial status, stock details, and major events as of February 10, 2025. Essential for investors!
Explore Fulcrum Therapeutics, Inc.'s latest 8-K filing from January 13, 2025. Stay informed on important updates affecting common stock (Ticker: FULC) and investor interests.
Discover the latest SEC filing from Akebia Therapeutics, Inc. detailing significant events affecting operations and stock. Important insights for shareholders and investors.
Explore Scholar Rock Holding Corporation's 8-K report detailing significant developments on January 13, 2025. Key insights on stock and financial information included.
Explore Foghorn Therapeutics Inc.'s 8-K report covering a significant event on December 29, 2024. Learn about its common stock, NASDAQ listing, and corporate transparency.